|Bid||158.14 x 8200|
|Ask||158.39 x 33300|
|Day's range||156.48 - 158.32|
|52-week range||117.19 - 158.32|
|PE ratio (TTM)||44.51|
|Earnings date||12 Aug. 2015 - 18 Aug. 2015|
|Forward dividend & yield||1.21 (1.33%)|
|1y target est||125.33|
The CSL Limited (ASX:CSL) share price rose 5% to $148.88 after the company reported a 35% increase in profit this morning.
The CSL Limited (ASX:CSL) share price climbed 1.55% to $149.84 this week, despite the company not releasing any announcements to the market.
According to Bloomberg, top strategists at Goldman Sachs are predicting a market correction in global equities of between 10% and 20% in the coming months. What does this mean for your portfolio?
The healthcare sector has rallied ahead of the market and this reporting season will determine which stocks can keep outperforming. Here are two that are tipped to beat market expectations.
Hearing implant manufacturer Cochlear Limited (ASX:COH) has not had a positive start to 2018, with its share price down 4% to $164.25 at the time of writing. Since hitting an intraday high of $187.60 on November 28, Cochlear shares have lost over 12% despite the bullish sentiment across global equity markets.
It's happening right under our noses! The Aussie battler has notched up its 14th consecutive day of gains and it's having an impact on our share market.
I think the CSL Limited (ASX:CSL) share price and the Ramsay Health Care Limited (ASX:RHC) share price could move higher in 2018…